Back to 
UBS Group AG
UBS Group AG
PBM1 quarters
Position history for UBS Group AG's holdings in PSYENCE BIOMEDICAL LTD
Yes. Ubs holds 60 shares of PBM (Psyence Biomedical), worth $184, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$184
Current Shares
60
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of PBM: MORGAN STANLEY, JANE STREET GROUP, LLC, XTX Topco Ltd, CITADEL ADVISORS LLC